Page 20 - Journal of Structural Heart Disease Volume 1, Issue 3

Original Scientific Article
126
PRISE II study. J Am Coll Cardiol. 2014;64:
1339-1348. DOI: 10.1016/j.jacc.2014.05.067
23. Bijuklic K, Tübler T, Low RI, Grube E, Schofer J. Direct Flow Medical valve. EuroInter- vention. 2012;8(Suppl. Q):Q75-78. DOI:
10.4244/EIJV8SQA13
24. Schofer J, Colombo A, Klugmann S, Fajadet J, DeMarco F, Tchétché D, et al. Prospec- tive multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63:763-768. DOI: 10.1016/j.jacc.2013.10.013
25. Manoharan G, Spence MS, Rodés-Cabau J, Webb JG. St Jude Medical Portico valve. Eu- roIntervention. 2012;8(Suppl. Q):Q97–101. DOI: 10.4244/EIJV8SQA18
26. Willson AB, Rodès-Cabau J, Wood DA, Leipsic J, Cheung A, Toggweiler S, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Car- diol. 2012;60:581-586. DOI: 10.1016/j. jacc.2012.02.045
27. Urena M, Doyle D, Rodés-Cabau J, Dumont E. Initial experience of transcatheter aortic valve replacement with the St Jude Med- ical Portico valve inserted through the transapical approach. J Thorac Cardiovasc Surg. 2013;146:e24-27. DOI: 10.1016/j. jtcvs.2013.06.005
28. Ribeiro HB, Urena M, Kuck K-H, Webb JG, Rodés-Cabau J. Edwards CENTERA valve. EuroIntervention. 2012;8(Suppl. Q):Q79- 82. DOI: 10.4244/EIJV8SQA14
29. Binder RK, Schäfer U, Kuck K-H, Wood DA, Moss R, Leipsic J, et al. Transcatheter aor- tic valve replacement with a new self-ex- panding transcatheter heart valve and motorized delivery system. JACC Cardio- vasc Interv. 2013;6:301-307. DOI: 10.1016/j. jcin.2013.01.129
30. Sievert H. The Venus A TAVR system. Pre- sented at TVT 2015.
31. Treede H, Rastan A, Ferrari M, Ensminger S, Figulla H-R, Mohr F-W. JenaValve. EuroInt- ervention. 2012;8(Suppl. Q):Q88-93. DOI: 10.4244/EIJV8SQA16
32. Seiffert M, Diemert P, Koschyk D, Schirmer J, Conradi L, Schnabel R, et al. Transapi- cal implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc. Interv. 2013;6:590-597. DOI: 10.1016/j.jcin.2013.01
33.Rudolph TK, Baldus S. JenaValve– Transfemoral technology. EuroInter- vention. 2013;9(Suppl.):S101-102. DOI: 10.4244/EIJV9SSA20
34. Treede H, Mohr F-W, Baldus S, Rastan A, En- sminger S, Arnold M, et al. Transapical tran-
scatheter aortic valve implantation using the JenaValveTM system: Acute and 30-day results of the multicentre CE-mark study. Eur J Cardio-Thorac Surg. 2012;41:e131- 138. DOI: 10.1093/ejcts/ezs129
35. Kempfert J, Möllmann H, Walther T. Syme- tis ACURATE TA valve. EuroIntervention. 2012;8(Suppl. Q):Q102-109. DOI: 10.4244/ EIJV8SQA19
36. Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A. Symetis ACU- RATE TFTM aortic bioprosthesis. EuroInt- ervention. 2013;9(Suppl.):S107-110. DOI: 10.4244/EIJV9SSA22
37. Kempfert J, Treede H, Rastan AJ, Schön- burg M, Thielmann M, Sorg S, et al. Tran- sapical aortic valve implantation using a new self-expandable bioprosthesis (ACU- RATE TATM): 6-month outcomes. Eur J Car- dio-Thorac Surg. 2013;43:52-56, 57. DOI: 10.1093/ejcts/ezs139
38. Seiffert M, Conradi L, Kloth B, Koschyk D, Schirmer J, Schnabel RB, et al. Single- centre experience with next-generation devices for transapical aortic valve implantation. Eur J Cardio-Thorac Surg. 2014. DOI: 10.1093/ejcts/ezu041
39. Sündermann SH, Grünenfelder J, Corti R, Rastan AJ, Linke A, Lange R, et al. Feasibil- ity of the EngagerTM aortic transcatheter valve system using a flexible over-the- wire design. Eur. J. Cardio-Thorac. Surg. 2012;42:e48-52. DOI: 10.1093/ejcts/ezs389
40.Sündermann SH, Holzhey D, Bleiziffer S, Treede H, Falk V. Medtronic Engag- erTM bioprosthesis for transapical tran- scatheter aortic valve implantation. EuroIntervention. 2013;9(Suppl.):S97-100. DOI: 10.4244/EIJV9SSA19
41. Holzhey D, Linke A, Treede H, Baldus S, Bleiziffer S, Wagner A, et al. Intermediate follow-up results from the multicenter en- gager European pivotal trial. Ann Thorac Surg. 2013;96:2095-2100. DOI: 10.1016/j. athoracsur.2013.06.089
42. Barbanti M, Ye J, Pasupati S, El-Gamel A, Webb JG. The Helio transcatheter aortic dock for patients with aortic regurgitation. EuroIntervention. 2013;9(Suppl.):S91-94. DOI: 10.4244/EIJV9SSA17
43. Pasupati S. A novel approach to aortic in- sufficiency: Edwards Helio System—Feasi- bility trial. Presented at EuroPCR 2013.
44. Stortecky S, Windecker S, Pilgrim T, Heg D, Buellesfeld L, Khattab AA, et al. Cerebro- vascular accidents complicating transcath- eter aortic valve implantation: frequency, timing and impact on outcomes. EuroIn- tervention. 2012;8:62-70. DOI: 10.4244/ EIJV8I1A11
45. Rodés-Cabau J, Kahlert P, Neumann F-J, Schymik G, Webb JG, Amarenco P, et al. Feasibility and exploratory efficacy eval- uation of the umbrella embolic deflec- tor system for the prevention of cerebral emboli in patients undergoing tran- scatheter aortic valve replacement: The PROTAVI-C Pilot Study. JACC Cardiovasc Interv. 2014;7:1146-1155. DOI: 10.1016/j. jcin.2014.04.019
46. Praz F, Nietlispach F. Cerebral protec- tion devices for transcatheter aortic valve implantation: is better the enemy of good? EuroIntervention. 2013;9(Sup- pl.):S124-128. DOI: 10.4244/EIJV9SSA26
47. Onsea K, Agostoni P, Samim M, Voskuil M, Kluin J, Budde R, et al. First-in-man expe- rience with a new embolic deflection de- vice in transcatheter aortic valve interven- tions. EuroIntervention. 2012;8:51-56. DOI: 10.4244/EIJV8I1A9
48. Lansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, et al. A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015 May 19. [Epub ahead of print]. DOI:10.1093/eurheartj/ehv191
49. Naber CK, Ghanem A, Abizaid AA, Wolf A, Sinning J-M, Werner N, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aor- tic valve implantation. EuroIntervention. 2012;8:43-50. DOI: 10.4244/EIJV8I1A8
50. Linke A. CLEAN-TAVI: A prospective, ran- domized trial of cerebral embolic protec- tion in high-risk patients with aortic steno- sis undergoing transcatheter aortic valve replacement. Presented at TCT 2014.
Structural Heart Disease, August 2015
Volume 1, Issue 3: 112-126
Cite this article as: Abramowitz Y, Chakravarty T, Jilaihawi H. Makkar RR. Update on new devices for transcath- eter aortic valve replacement. Struc- tural Heart Disease 2015;1(3):112-126. DOI: http://dx.doi.org/10.12945/j. jshd.2015.019-14